Press Releases Year None202120202019 January 11, 2021 Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021 January 4, 2021 Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference January 4, 2021 Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
January 4, 2021 Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
